Lyell Immunopharma, Inc.
Institutional Ownership & Holdings Analysis
About
lyell-immunopharma is a publicly traded company tracked by institutional investors. This page displays information about the institutional ownership of the company's shares, showing which investment funds and asset managers hold positions in the company.
Top Institutional Holders
| # | Institution | Value |
|---|---|---|
| 1 | MWG Management Ltd.(2025-03-31) | $10.8M |
| 2 | Foresite Capital Management IV, LLC(2025-03-31) | $8.6M |
| 3 | Orland Properties Ltd(2025-03-31) | $8.2M |
| 4 | BlackRock, Inc.(2025-03-31) | $6.8M |
| 5 | Decheng Capital LLC(2025-03-31) | $6.4M |
| 6 | VANGUARD GROUP INC(2025-03-31) | $5.2M |
| 7 | Foresite Capital Management V, LLC(2025-03-31) | $4.4M |
| 8 | venBio Partners LLC(2025-03-31) | $3.8M |
| 9 | PRICE T ROWE ASSOCIATES INC /MD/(2025-03-31) | $3.5M |
| 10 | Alphabet Inc.(2025-03-31) | $3.2M |
| 11 | GEODE CAPITAL MANAGEMENT, LLC(2025-03-31) | $2.4M |
| 12 | CITADEL ADVISORS LLC(2025-03-31) | $2.4M |
| 13 | STATE STREET CORP(2025-03-31) | $2.0M |
| 14 | ORBIMED ADVISORS LLC(2024-12-31) | $2.0M |
| 15 | HSG Holding Ltd(2025-03-31) | $1.5M |
| 16 | Almitas Capital LLC(2025-03-31) | $1.3M |
| 17 | RENAISSANCE TECHNOLOGIES LLC(2025-03-31) | $951.5K |
| 18 | MIC Capital Management UK LLP(2025-03-31) | $936.4K |
| 19 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC(2025-03-31) | $863.3K |
| 20 | NORTHERN TRUST CORP(2025-03-31) | $696.6K |
As of 2025-03-31
Value:$10.8M
As of 2025-03-31
Value:$8.6M
As of 2025-03-31
Value:$8.2M
As of 2025-03-31
Value:$6.8M
As of 2025-03-31
Value:$6.4M
As of 2025-03-31
Value:$5.2M
As of 2025-03-31
Value:$4.4M
As of 2025-03-31
Value:$3.8M
As of 2025-03-31
Value:$3.5M
As of 2025-03-31
Value:$3.2M
As of 2025-03-31
Value:$2.4M
As of 2025-03-31
Value:$2.4M
As of 2025-03-31
Value:$2.0M
As of 2024-12-31
Value:$2.0M
As of 2025-03-31
Value:$1.5M
As of 2025-03-31
Value:$1.3M
As of 2025-03-31
Value:$951.5K
As of 2025-03-31
Value:$936.4K
As of 2025-03-31
Value:$863.3K
As of 2025-03-31
Value:$696.6K
Total Institutional Holders:122
Top 10 Holders Own:72.6%